Skip to main content
. Author manuscript; available in PMC: 2022 Jun 9.
Published in final edited form as: J Magn Reson Imaging. 2016 Mar 17;44(4):794–803. doi: 10.1002/jmri.25236

TABLE 3.

Anatomic, Metabolic, and Functional Features of PNSTs in SWN

Anatomic imaging features (n = 153)
Sizea 2.3 cm (1–24.3 cm)
Margin
 • Well defined 94% (143/149)
 • Partly well defined 3% (5/149)
 • Ill defined 1% (1/149)
T1-W
 • Signal characteristics
  ○ Hypointense 1% (1/149)
  ○ Isointense 99% (148/149)
  ○ Hyperintense 0%
 • Heterogeneity
  ○ < 25% 99% (148/149)
  ○ 25–75% 1% (1/149)
  ○ > 75% 0%
STIR
 • Signal characteristics
  ○ Hypointense 0%
  ○ Isointense 0%
  ○ Hyperintense 100% (149/149)
 • Heterogeneity
  ○ < 25% 19% (28/149)
  ○ 25–75% 66% (99/149)
  ○ > 75% 15% (22/149)
T1W +C Enhancement
  ○ < 25% 19% (23/123)
  ○ 25–75% 22% (27/123)
  ○ > 75% 59% (73/123)
Target sign on STIR
 • Absent 33% (34/149)
 • Present 77% (115/149)
Tail sign
 • Absent 64% (96/149)
 • Present 36% (53/149)
Split fat sign
 • Absent 4% (6/149)
 • Present 96% (143/149)
Relationship of lesion to parent nerve
 • Central 2% (3/149)
 • Eccentric 33% (50/149)
 • Indeterminate 65% (96/149)
Functional imaging features (n = 98)
ADC values (×10−3 mm2/s)
 • Minimuma 1.7 (0.3–2.2)
 • Averagea 2.1 (0.9–2.9)
 • Maximuma 2.5 (1–4.8)
Target Sign
 • Absent 80% (78/98)
 • Present 20% (20/98)
Metabolic imaging features (n = 15)
SUVmax – Earlya 6 (2.1–11.7)
SUVmax – Delayeda 10 (2.7–15.3)
a

Median values are provided with range in parentheses (averaged for both readers).